211 related articles for article (PubMed ID: 16205958)
21. QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents.
Habibpour E; Ahmadi S
Curr Comput Aided Drug Des; 2017; 13(2):143-159. PubMed ID: 28120704
[TBL] [Abstract][Full Text] [Related]
22. Development of quantitative structure-activity relationships for the toxicity of aromatic compounds to Tetrahymena pyriformis: comparative assessment of the methodologies.
Cronin MT; Schultz TW
Chem Res Toxicol; 2001 Sep; 14(9):1284-95. PubMed ID: 11559045
[TBL] [Abstract][Full Text] [Related]
23. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
[TBL] [Abstract][Full Text] [Related]
24. Modeling of activity of cyclic urea HIV-1 protease inhibitors using regularized-artificial neural networks.
Fernández M; Caballero J
Bioorg Med Chem; 2006 Jan; 14(1):280-94. PubMed ID: 16202604
[TBL] [Abstract][Full Text] [Related]
25. QSAR modeling of AT1 receptor antagonists using ANN.
Su Q; Zhou L
J Mol Model; 2006 Sep; 12(6):869-75. PubMed ID: 16541251
[TBL] [Abstract][Full Text] [Related]
26. Neural networks studies: quantitative structure-activity relationships of antifungal 1.
Mghazli S; Jaouad A; Mansour M; Villemin D; Cherqaoui D
Chemosphere; 2001 Apr; 43(3):385-90. PubMed ID: 11302584
[TBL] [Abstract][Full Text] [Related]
27. A self-adaptive genetic algorithm-artificial neural network algorithm with leave-one-out cross validation for descriptor selection in QSAR study.
Wu J; Mei J; Wen S; Liao S; Chen J; Shen Y
J Comput Chem; 2010 Jul; 31(10):1956-68. PubMed ID: 20512843
[TBL] [Abstract][Full Text] [Related]
28. QSAR of heterocyclic antifungal agents by flip regression.
Deeb O; Clare BW
J Comput Aided Mol Des; 2008 Dec; 22(12):885-95. PubMed ID: 18574697
[TBL] [Abstract][Full Text] [Related]
29. Bi- and multilinear PLS coupled to MIA-QSAR in the prediction of antifungal activities of some benzothiazole derivatives.
Bitencourt M; Freitas MP
Med Chem; 2009 Jan; 5(1):79-86. PubMed ID: 19149653
[TBL] [Abstract][Full Text] [Related]
30. QSAR studies of bioactivities of 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 receptor ligands using physicochemical descriptors and MLR and ANN-modeling.
Goodarzi M; Freitas MP; Ghasemi N
Eur J Med Chem; 2010 Sep; 45(9):3911-5. PubMed ID: 20547432
[TBL] [Abstract][Full Text] [Related]
31. Comparison of linear and nonlinear classification algorithms for the prediction of drug and chemical metabolism by human UDP-glucuronosyltransferase isoforms.
Sorich MJ; Miners JO; McKinnon RA; Winkler DA; Burden FR; Smith PA
J Chem Inf Comput Sci; 2003; 43(6):2019-24. PubMed ID: 14632453
[TBL] [Abstract][Full Text] [Related]
32. Artificial neural network prediction of retention factors of some benzene derivatives and heterocyclic compounds in micellar electrokinetic chromatography.
Golmohammadi H; Fatemi MH
Electrophoresis; 2005 Sep; 26(18):3438-44. PubMed ID: 16110463
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents.
Zhao S; Zhang X; Wei P; Su X; Zhao L; Wu M; Hao C; Liu C; Zhao D; Cheng M
Eur J Med Chem; 2017 Sep; 137():96-107. PubMed ID: 28558334
[TBL] [Abstract][Full Text] [Related]
34. Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses.
Caballero J; Fernández M; González-Nilo FD
Bioorg Med Chem; 2008 Jun; 16(11):6103-15. PubMed ID: 18468903
[TBL] [Abstract][Full Text] [Related]
35. Molecular modeling of azole antifungal agents active against Candida albicans. 1. A comparative molecular field analysis study.
Tafi A; Anastassopoulou J; Theophanides T; Botta M; Corelli F; Massa S; Artico M; Costi R; Di Santo R; Ragno R
J Med Chem; 1996 Mar; 39(6):1227-35. PubMed ID: 8632429
[TBL] [Abstract][Full Text] [Related]
36. QSPR studies of impact sensitivity of nitro energetic compounds using three-dimensional descriptors.
Xu J; Zhu L; Fang D; Wang L; Xiao S; Liu L; Xu W
J Mol Graph Model; 2012 Jun; 36():10-9. PubMed ID: 22503858
[TBL] [Abstract][Full Text] [Related]
37. Measurement and ANN prediction of pH-dependent solubility of nitrogen-heterocyclic compounds.
Sun F; Yu Q; Zhu J; Lei L; Li Z; Zhang X
Chemosphere; 2015 Sep; 134():402-7. PubMed ID: 25985098
[TBL] [Abstract][Full Text] [Related]
38. QSAR study of antimicrobial activity of some 3-nitrocoumarins and related compounds.
Debeljak Z; Skrbo A; Jasprica I; Mornar A; Plecko V; Banjanac M; Medić-Sarić M
J Chem Inf Model; 2007; 47(3):918-26. PubMed ID: 17489552
[TBL] [Abstract][Full Text] [Related]
39. QSAR study of malonyl-CoA decarboxylase inhibitors using GA-MLR and a new strategy of consensus modeling.
Li J; Lei B; Liu H; Li S; Yao X; Liu M; Gramatica P
J Comput Chem; 2008 Dec; 29(16):2636-47. PubMed ID: 18484640
[TBL] [Abstract][Full Text] [Related]
40. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.
Votano JR; Parham M; Hall LM; Hall LH; Kier LB; Oloff S; Tropsha A
J Med Chem; 2006 Nov; 49(24):7169-81. PubMed ID: 17125269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
